FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
Ripley Anne-Marie Juliette
   2. Issuer Name and Ticker or Trading Symbol
SECOND SIGHT MEDICAL PRODUCTS INC [EYES] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
VP Regulatory Affairs
(Last)
(First)
(Middle)
12744 SAN FERNANDO ROAD, BLDG. 3		 3. Date of Earliest Transaction (Month/Day/Year)
06/04/2015
(Street)

SYLMAR, CA 91342		 4. If Amendment, Date Original Filed(Month/Day/Year)
 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)		 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code
(Instr. 8)		 4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)		 5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)		 6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)		 7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
COMMON STOCK 06/04/2015   M   4,371 (1) A $ 4.75 4,371 D  
COMMON STOCK 06/04/2015   S   4,371 (2) D $ 15 (3) 0 D  

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)		 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code
(Instr. 8)		 5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)		 6. Date Exercisable and Expiration Date
(Month/Day/Year)		 7. Title and Amount of Underlying Securities
(Instr. 3 and 4)		 8. Price of Derivative Security
(Instr. 5)		 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)		 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)		 11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Option $ 4.75 06/04/2015   M     4,371   (3) 09/01/2015 Common Stock 4,371 $ 0 0 D  
Option $ 4.75               (3) 01/01/2016 Common Stock 2,500   2,500 D  
Option $ 5               (3) 01/01/2017 Common Stock 6,125   6,125 D  
Option $ 5               (3) 04/01/2018 Common Stock 4,750   4,750 D  
Option $ 5               (3) 11/01/2018 Common Stock 25,000   25,000 D  
Option $ 5               (3) 02/01/2019 Common Stock 6,750   6,750 D  
Option $ 5               (3) 02/01/2020 Common Stock 10,125   10,125 D  
Option $ 5               (3) 02/01/2020 Common Stock 10,625   10,625 D  
Option $ 5               (3) 03/01/2021 Common Stock 8,313   8,313 D  
Option $ 5               (3) 03/01/2022 Common Stock 5,813   5,813 D  
Option $ 5               (3) 04/01/2024 Common Stock 3,125   3,125 D  

Reporting Owners

Reporting Owner Name / Address Relationships
 Director  10% Owner  Officer  Other
Ripley Anne-Marie Juliette
12744 SAN FERNANDO ROAD, BLDG. 3
SYLMAR, CA 91342		       VP Regulatory Affairs  

Signatures

 /s/ Anne-Marie Ripley   06/08/2015
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) Ms. Ripley exercised 4,371 vested options (which expire on September 1, 2015) reported as Option(1) on Form 3 filed with the SEC on November 18, 2014.
(2) These transactions were effected pursuant to planned sales under lock-up agreement entered into at the time of EYES IPO in November 2014, as approved by Board of EYES and the IPO underwriter and as further disclosed in the Company's prospectus dated November 20, 2014.
(3) These are vested employee options currently exercisable.
 
Remarks:
Excludes employee options, covering 89,781 shares, not exercisable for over 60 days from this date. Sales reported in this Form 4 constitute the final trades contemplated upon expiration of the six month lock-up noted in footnote 2 above, with the Reporting Person's share sales after this date remaining subject to a 12 month lock-up that commenced from the IPO date.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.